Bold integration of biomedical and behavioral science will result in successful HIV Prevention. Our Prevention Core leadership includes Co-Directors Michelle Lally, MD, MSc and Larry Brown, MD. With a shared passion for HIV prevention and a shared vision of novel """"""""biobehavioral"""""""" approaches to HIV prevention. Dr. Lally investigates HIV Vaccines and PrEP, and Dr. Brown's extensive experience and expertise is in behavioral science. Additional Core Faculty, all superb and each committed to the combination of biomedical and behavioral science, include Michael Carey, PhD, Director of Centers for Behavioral and Preventive Medicine at Lifespan, Don Operario, PhD, Director of Graduate Program in Behavioral and Social Sciences Intervention, Brown Program in Public Health, Kate Morrow, PhD (microbicide acceptability). Curt Beckwith, MD (HIV testing and treatment among prisoners and other marginalized populations), Steve Hong, MD (international HIV primary and secondary prevention), and Kenneth Mayer, MD (broad HIV prevention experience and expertise). A red ribbon imprinted with """"""""B &B"""""""" is our Core's logo, which has been effective at promoting the Biomedical &Behavioral branding of our Prevention Core.
Our Aims are to provide HIV prevention researchers (students /junior investigators / experienced investigators) with consultation and mentorship, education and training, and support services that are consistently inclusive of both biomedical and behavioral science.
Aims will be achieved through effective advertising of our services, individual consultations and ongoing mentorship of junior investigators, education and training (on a weekly, monthly, quarterly, or annual basis), and community collaboration. Expected outcomes are sustained and increased funding for research related to HIV prevention among our investigators, continued growth in the number of Core users, increased frequency of use of Core services, and a steady increase in the number of individual prevention projects that cleariy incorporate both biomedical and behavioral science. Outcomes will be tracked and measured, and adjustments will be made to our approaches as necessary to assure that outcomes are achieved.
HIV is a preventable infection, and AIDS is a preventable disease;yet prevention success can be achieved only when effective biological products are combined with requisite behavioral methodologies. The Prevention Core proposes to strategically support HIV prevention efforts with a combination of biomedical and behavioral science through the provision of expert
|Tarantino, Nicholas; Brown, Larry K; Whiteley, Laura et al. (2018) Correlates of missed clinic visits among youth living with HIV. AIDS Care 30:982-989|
|Wurcel, Alysse G; Burke, Deirdre J; Wang, Jianing J et al. (2018) The Burden of Untreated HCV Infection in Hospitalized Inmates: a Hospital Utilization and Cost Analysis. J Urban Health 95:467-473|
|Kahler, Christopher W; Pantalone, David W; Mastroleo, Nadine R et al. (2018) Motivational interviewing with personalized feedback to reduce alcohol use in HIV-infected men who have sex with men: A randomized controlled trial. J Consult Clin Psychol 86:645-656|
|Nunn, Amy; Parker, Sharon; McCoy, Katryna et al. (2018) African American Clergy Perspectives About the HIV Care Continuum: Results From a Qualitative Study in Jackson, Mississippi. Ethn Dis 28:85-92|
|Brinkley-Rubinstein, Lauren; Macmadu, Alexandria; Marshall, Brandon D L et al. (2018) Risk of fentanyl-involved overdose among those with past year incarceration: Findings from a recent outbreak in 2014 and 2015. Drug Alcohol Depend 185:189-191|
|Gamarel, Kristi E; Westfall, Andrew O; Lally, Michelle A et al. (2018) Tobacco Use and Sustained Viral Suppression in Youth Living with HIV. AIDS Behav 22:2018-2025|
|Claborn, Kasey; Becker, Sara; Operario, Don et al. (2018) Adherence intervention for HIV-infected persons who use drugs: adaptation, open trial, and pilot randomized hybrid type 1 trial protocol. Addict Sci Clin Pract 13:12|
|Lee, Hana; Hogan, Joseph W; Genberg, Becky L et al. (2018) A state transition framework for patient-level modeling of engagement and retention in HIV care using longitudinal cohort data. Stat Med 37:302-319|
|Cioe, Patricia A; Guthrie, Kate M; Freiberg, Matthew S et al. (2018) Cardiovascular Risk Reduction in Persons Living With HIV: Treatment Development, Feasibility, and Preliminary Results. J Assoc Nurses AIDS Care 29:163-177|
|Restar, Arjee; Nguyen, Mary; Nguyen, Kimberly et al. (2018) Trends and emerging directions in HIV risk and prevention research in the Philippines: A systematic review of the literature. PLoS One 13:e0207663|
Showing the most recent 10 out of 806 publications